US 7,507,741 B2
Heterocyclic compounds
George Stuart Cockerill, Maulden (United Kingdom); and Karen Elizabeth Lackey, Durham, N.C. (US)
Assigned to SmithKline Beecham Corporation, Philadelphia, Pa. (US)
Filed on Aug. 01, 2007, as Appl. No. 11/832,187.
Application 11/832187 is a division of application No. 11/562047, filed on Nov. 21, 2006, granted, now 7,265,123.
Application 11/562047 is a division of application No. 11/400284, filed on Apr. 07, 2006, granted, now 7,189,734.
Application 11/400284 is a division of application No. 11/061578, filed on Feb. 18, 2005, granted, now 7,084,147.
Application 11/061578 is a division of application No. 10/030527, granted, now 6,933,299, previously published as PCT/US00/18128, filed on Jun. 30, 2000.
Claims priority of application No. 9916213.3 (GB), filed on Jul. 09, 1999; and application No. 9916218.2 (GB), filed on Jul. 09, 1999.
Prior Publication US 2008/0004294 A1, Jan. 03, 2008
Int. Cl. C07D 405/04 (2006.01); A61K 31/505 (2006.01)
U.S. Cl. 514—266.24  [544/293] 8 Claims
 
1. 2-{{[5-(4-{3-chloro-4-[(3-fluorobenzyl)oxy]anilino}-6-quinazolinyl)-2-furyl]methyl}[2-(methylsulfonyl)ethyl]amino}acetonitrile or a salt thereof.